<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Brain <z:chebi fb="0" ids="51349">polyamines</z:chebi> have been associated with posttraumatic vasogenic <z:hpo ids='HP_0000969'>edema</z:hpo> and blood-brain barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) breakdown seen in some models of brain injury </plain></SENT>
<SENT sid="1" pm="."><plain>We hypothesized that the inhibition of the enzyme responsible for <z:chebi fb="0" ids="51349">polyamine</z:chebi> production with the decarboxylase difluoromethylornithine (DFMO) may decrease <z:chebi fb="2" ids="33602">BBB</z:chebi> breakdown after a focal brain <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="2" pm="."><plain>Thirty-two cats underwent 8 hours of middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> and one of four treatments: sham operation (Sham), <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> (Isc), <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/DFMO (Isc/DF), and <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e>/DFMO/<z:chebi fb="0" ids="17148">putrescine</z:chebi> (Isc/DF/PU) </plain></SENT>
<SENT sid="3" pm="."><plain>The regional brain specific gravity and the volume of Evans blue (EB) extravasation were measured at the time of <z:hpo ids='HP_0011420'>death</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>The groups were monitored for temperature, heart rate, blood pressure, and arterial blood gases, and the values did not differ outside <z:mpath ids='MPATH_458'>normal</z:mpath> physiological ranges </plain></SENT>
<SENT sid="5" pm="."><plain>EB results were expressed as the percentage of the hemisphere stained and showed the following: Sham, 2.23%; Isc, 32.8%; Isc/DF, 5.6%; Isc/DF/PU, 36.3% </plain></SENT>
<SENT sid="6" pm="."><plain>As a measure of <z:chebi fb="2" ids="33602">BBB</z:chebi>, <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> increased EB staining; DFMO pretreatment decreased the amount of EB staining to control levels; and the <z:chebi fb="0" ids="51349">polyamine</z:chebi> <z:chebi fb="0" ids="17148">putrescine</z:chebi> abolished the protective effect of DFMO (<z:hpo ids='HP_0000001'>all</z:hpo> significant at P = 0.05) </plain></SENT>
<SENT sid="7" pm="."><plain>DFMO pretreatment also resulted in a significant (P = 0.05) return to control values for specific gravity in the EB-stained regions (1.0328) of ischemic animals </plain></SENT>
<SENT sid="8" pm="."><plain>This effect was present primarily in the white matter </plain></SENT>
<SENT sid="9" pm="."><plain>Treatment with DFMO, an <z:chebi fb="0" ids="18257">ornithine</z:chebi> decarboxylase inhibitor, significantly decreased postischemic <z:chebi fb="2" ids="33602">BBB</z:chebi> breakdown and vasogenic <z:hpo ids='HP_0000969'>edema</z:hpo> in this model </plain></SENT>
</text></document>